The Learning Design Manifesto: What we value, resist and might build?
ASCILITE Publications · 17.11.2026 · 79-81
DOI: 10.65106/apubs.2026.3227 ↗Kurz gefasst
Fachartikel in der Zeitschrift ASCILITE Publications, online erschienen am 17.11.2026. Verfasst von Keith Heggart und 6 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Learning design is increasingly central to higher education, yet practitioners continue to grapple with questions of identity, recognition and collective purpose. Building on previous ASCILITE conversations about professional standards for learning design, this working symposium builds upon previous symposia on this theme to move from questions about what learning designers do to what learning design stands for. Participants will be invited to co-author draft principles for a Learning Design Manifesto, articulating the values, commitments and purposes that should guide the field in a period shaped by generative AI, institutional reform, hybrid education and demands for scalability. Through short provocations based on existing research, guided group work and live synthesis, participants will develop, test and prioritise candidate principles.
Zitieren
APA
Heggart, K., Henderson, M., Nguyen, N., Babai, H., Dave, K., Simpson, C., & Rushton, D. (2026). The Learning Design Manifesto: What we value, resist and might build?. ASCILITE Publications, 79-81. https://doi.org/10.65106/apubs.2026.3227
Vancouver
Heggart K, Henderson M, Nguyen N, Babai H, Dave K, Simpson C, et al. The Learning Design Manifesto: What we value, resist and might build?. ASCILITE Publications. 2026:79-81. doi:10.65106/apubs.2026.3227
BibTeX
@article{Heggart2026,
author = {Heggart, Keith and Henderson, Michael and Nguyen, Nhung and Babai, Homa and Dave, Kashmira and Simpson, Colin and Rushton, Dominic},
title = {The Learning Design Manifesto: What we value, resist and might build?},
journal = {ASCILITE Publications},
year = {2026},
pages = {79--81},
doi = {10.65106/apubs.2026.3227}
}
EUVIMED